Eli Lilly-Backed Biotech TRex Dips 3.6% After $116.7 Million IPO
TRex Bio Inc. shares slipped 3.6% in the firm’s trading debut, after the biotech raised $116.7 million in a US initial public offering.
By Avalon Pernell · Bloomberg
TRex Bio Inc. shares slipped 3.6% in the firm’s trading debut, after the biotech raised $116.7 million in a US initial public offering.